ID

38074

Descripción

Two-Part Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Pharmacodynamics of Repeat Oral Dosesof the Enteric-Coated Free Base Formulation of Darapladib (SB-480848) ina Dose Rising Fashion and to Evaluate the Safety, Tolerability and Pharmacokinetics of Darapladib when Co-administered with Ketoconazole in Healthy Adult Subjects. There are 4 parts to this study: Screening, Part A, Part B, and Follow-Up. Part A contains 2 Sessions per day for day 1-10, Part B contains 1 Session per day for day 1-14. Each itemgroup contains information when it should be filled out. The itemgroups of the non-serious and serious adverse event forms contain additional information on the definition of a serious/non-serious adverse event.

Palabras clave

Versiones (1)
  1. 15/9/19 15/9/19 -
Titular de derechos de autor

GlaxoSmithKline

Subido en

15 de septiembre de 2019

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Darapladib Evaluation Case Report Form GSK LPL107988

Inglés

Concomitant Medication

12 formularios  
Administrative documentation
Descripción

Administrative documentation

Subject Identifier
Descripción

Subject Identifier

Tipo de datos

text

Alias
UMLS CUI [1]
C2348585
Visit Date
Descripción

Visit Date

Tipo de datos

date

Alias
UMLS CUI [1]
C1320303
Concomitant medications
Descripción

Concomitant medications

Alias
UMLS CUI-1
C2347852
Were any concomitant medications taken by the subject prior to dosing and/or during the study?
Descripción

If Yes, record each medication on a separate line using Trade Names where possible. If the medication is related to a Non-Serious Adverse Event or Serious Adverse Event, details should be expressed using the same terminology.

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C2347852
UMLS CUI [1,2]
C0332152
UMLS CUI [1,3]
C0008976
UMLS CUI [2,1]
C2347852
UMLS CUI [2,2]
C0347984
UMLS CUI [2,3]
C0008976
Concomitant medications information
Descripción

Concomitant medications information

Alias
UMLS CUI-1
C2347852
UMLS CUI-2
C1533716
Drug Name
Descripción

Drug Name

Tipo de datos

text

Alias
UMLS CUI [1,1]
C2347852
UMLS CUI [1,2]
C0027365
Unit Dose
Descripción

Unit Dose

Tipo de datos

float

Alias
UMLS CUI [1]
C2826646
Units
Descripción

Units

Tipo de datos

text

Alias
UMLS CUI [1]
C2826767
Frequency
Descripción

Frequency

Tipo de datos

float

Alias
UMLS CUI [1]
C2826654
Route
Descripción

Route of administration

Tipo de datos

text

Alias
UMLS CUI [1]
C2826730
Reason for medication
Descripción

Reason for medication

Tipo de datos

text

Alias
UMLS CUI [1]
C2826696
Start Date and Time
Descripción

Start Date and Time

Tipo de datos

datetime

Alias
UMLS CUI [1]
C2826734
UMLS CUI [2]
C2826740
Taken prior to study
Descripción

Taken prior to study

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C2347852
UMLS CUI [1,2]
C0332152
UMLS CUI [1,3]
C0008976
Stop Date and Time
Descripción

Stop Date and Time

Tipo de datos

datetime

Alias
UMLS CUI [1]
C2826744
UMLS CUI [2]
C2826659
Ongoing medication?
Descripción

Ongoing medication

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2826666
Volver a la parte superior de la página

Similar models

Concomitant Medication

12 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Administrative documentation
Subject Identifier
Item
Subject Identifier
text
C2348585 (UMLS CUI [1])
Visit Date
Item
Visit Date
date
C1320303 (UMLS CUI [1])
Item Group
Concomitant medications
C2347852 (UMLS CUI-1)
Concomitant medications
Item
Were any concomitant medications taken by the subject prior to dosing and/or during the study?
boolean
C2347852 (UMLS CUI [1,1])
C0332152 (UMLS CUI [1,2])
C0008976 (UMLS CUI [1,3])
C2347852 (UMLS CUI [2,1])
C0347984 (UMLS CUI [2,2])
C0008976 (UMLS CUI [2,3])
Item Group
Concomitant medications information
C2347852 (UMLS CUI-1)
C1533716 (UMLS CUI-2)
Drug Name
Item
Drug Name
text
C2347852 (UMLS CUI [1,1])
C0027365 (UMLS CUI [1,2])
Unit Dose
Item
Unit Dose
float
C2826646 (UMLS CUI [1])
Units
Item
Units
text
C2826767 (UMLS CUI [1])
Frequency
Item
Frequency
float
C2826654 (UMLS CUI [1])
Route of administration
Item
Route
text
C2826730 (UMLS CUI [1])
Reason for medication
Item
Reason for medication
text
C2826696 (UMLS CUI [1])
Start Date and Time
Item
Start Date and Time
datetime
C2826734 (UMLS CUI [1])
C2826740 (UMLS CUI [2])
Taken prior to study
Item
Taken prior to study
boolean
C2347852 (UMLS CUI [1,1])
C0332152 (UMLS CUI [1,2])
C0008976 (UMLS CUI [1,3])
Stop Date and Time
Item
Stop Date and Time
datetime
C2826744 (UMLS CUI [1])
C2826659 (UMLS CUI [2])
Ongoing medication
Item
Ongoing medication?
boolean
C2826666 (UMLS CUI [1])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial